CD154 (CD40L): A novel aid to document nonimmediate hypersensitivity to amoxicillin or amoxicillin clavulanic acid.

Athina L Van Gasse, Didier G Ebo, Christel M Mertens, Chris H Bridts, Jessy Elst, Leander De Puysseleyr, Margaretha A Faber, Margo M Hagendorens, Luc S De Clerck, Vito Sabato

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2021;50(5):640-642

PMID: 32056306

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Address: Department of Immunology, Faculty of Medicine and Health Sciences, Allergology, Rheumatology and the Infla-Med Centre of Excellence, University of Antwerp and Antwerp University Hospital, Antwerpen, Belgium.; Department of Paediatrics and the Infla-Med Centre of Excellence, Faculty of Medicine and Health Sciences, University of Antwerp, and Antwerp University Hospital, Antwerpen, Belgium.; Department of Immunology, Faculty of Medicine and Health Sciences, Allergology, Rheumatology and the Infla-Med Centre of Excellence, University of Antwerp and Antwerp University Hospital, Antwerpen, Belgium.; Department of Immunology and Allergology, AZ Jan Palfijn Gent, Ghent, Belgium.; Department of Immunology, Faculty of Medicine and Health Sciences, Allergology, Rheumatology and the Infla-Med Centre of Excellence, University of Antwerp and Antwerp University Hospital, Antwerpen, Belgium.

DOI: 10.1111/cea.13581

Link outs

Free resources

Medical:

https://medlineplus.gov/drugreactions.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Adolescent, Amoxicillin-Potassium Clavulanate Combination, CD40 Ligand, Child, Child, Preschool, Drug Hypersensitivity, Female, Humans, Male